Morphic Therapeutic
MORF
#4014
Rank
ยฃ2.13 B
Marketcap
ยฃ42.45
Share price
0.00%
Change (1 day)
143.00%
Change (1 year)

Revenue for Morphic Therapeutic (MORF)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of ยฃ0.4 Million a decrease over the revenue in the year 2022 that were of ยฃ58.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Morphic Therapeutic from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 ยฃ0.4 M-99.3%
2022 ยฃ58.52 M299.15%
2021 ยฃ14.66 M-55.53%
2020 ยฃ32.97 M154.7%
2019 ยฃ12.94 M389.37%
2018 ยฃ2.64 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.47 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA